Matthew Fleming is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the technology transactions department. His practice focuses on representing life science, medical device, and biotechnology companies with various commercial agreements and general corporate matters.

During law school, Matthew externed for the Delaware Court of Chancery and interned for the U.S. District Court of Delaware.

Prior to law school, Matthew worked at Johnson & Johnson in the biologics clinical pharmacology department focusing on clinical data and CRO management. Additionally, he has worked in various pharmaceutical roles including regulatory affairs at both Johnson & Johnson and GlaxoSmithKline. Matthew also more recently worked at Pfizer in their innovative health group.